Brief: Vaxart Appoints Steven Lo As CEO
06/03/2024 13:05
March 6 (Reuters) - Vaxart Inc VXRT.O :
* VAXART, INC. APPOINTS STEVEN LO AS PRESIDENT, CHIEF
EXECUTIVE
OFFICER, AND DIRECTOR
* APPOINTED STEVEN LO AS PRESIDENT AND CHIEF EXECUTIVE
OFFICER
EFFECTIVE AS OF MARCH 18, 2024
* MICHAEL J. FINNEY, PH.D. WILL STEP DOWN AS INTERIM CHIEF
EXECUTIVE OFFICER AND WILL CONTINUE TO SERVE AS CHAIR OF BOARD
Source text for Eikon: ID:nGNX4mp73t
Further company coverage: VXRT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts